The Sales & Marketing Effectiveness in Chemicals Forum will bring together industry leaders as well as experts responsible and deeply involved in sales and marketing strategies.
Let your knowledge about biosimilars grow as fast as the market
Learn more about Biosimilars and its grow on Brazilian and Latin American market.
SÃO PAULO, October 14, 2015 – Over the past ten years, regulatory authorities worldwide have been focusing on developing guidelines for biosimilars and countries keep investing in their development.Brazil's Ministry of Health spends US$ 1 billion annually on biopharmaceutical products; 41% of the total budget allocated to medicines. iBut more than $60 billion worth of patents on biological products are set to expire before 2020, representing a major opportunity for the pharmaceutical industry. And it really is major. The global biosimilars market is estimated to be worth $2.29 billion in 2015 and the forecast for 2020 is that it will grow 22.1% annually. iiIt is crucial to find answers, so we, at Fleming, decided to gather top representatives from major companies and regulatory authorities across Latin America, the USA and the EU, as well as local and international organizations, for Biosimilars LATAMThe conference will take place on 18 – 19 November 2015 in São Paulo, Brazil, and the program is designed to be highly interactive and dynamic. The main focus areas concern the current state and outlook of the industry, mainly adoption, price and regulation of biosimilars as well as market reality and expectations of investors.Gabriela Cezar from Pfizer, Brazil, will present an overview of the growing Brazilian and Latin American market, followed by Renato Porto, from ANVISA, with the latest updates on local regulations, guidelines and regulatory strategies.The second day will mainly focus on clinical and non-clinical development and market strategies. Also, we mustn't forget about our unique case study about Novex, the first mAb biosimilar approved in Argentina.Biosimilars are ready for prime time. Are you? Source:i,ii http://globenewswire.com/news-release/2015/07/22/7...
Interested in this topic?
Process Scale-Up in Pharma (Solid Dosage Forms)
The major objective of this course is to provide a detailed insight into the practical aspects and approaches of process scale-up for different unit operations and technologies.
Patient Adherence and Engagement
Discuss the issues of non-adherence with other stakeholders and find a solution together with the patients themselves.
Next Generation Antibody Therapeutics
This focused 2-day training will cover the discovery, engineering and production of next-generation antibodies, antibody fragments, bispecific Abs, innovative ADCs and more. Follow the path from their discovery and selection through engineering and expression to production and regulatory issues.
Turning Patient Feedback to Meaningful Resource for Care Delivery
Read the interview with Nasser Al Naimi, Deputy Chief Quality Officer at Hamad Medical Corporation, and Co-Director at Hamad Healthcare Quality Institute, and learn how to turn your data into strategic information to drive patient-family centered care.
Creating & Leading Patient Experience Excellence
Read the full interview with Dr. Ahmed Mohammad Abu-Abah, CEO at King Abdullah BinAbdulaziz University Hospital and gain insight into the creating & leading patient experience excellence.
Excelling in PV is not only about Technical Expertise
For a PV leader, to be successful can look like a daily Herculean work: meeting a crucial mandate to minimize harm to patients, while ensuring that a product is prescribed to the right population, and maintaining the highest level of compliance within a very complex set of worldwide regulations.